SOHM Inc | Adds Life to LivesAdds life to lives

SOHM, Inc., is in Discussion with Generic Pharmaceutical Company for the Majority of Stock Acquisitions as Vertical Integration

posted in Press Releases

CHINO HILLS, CA / July 27, 2022 / SOHM, Inc. (OTC PINK: SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, released more information today regarding updates on its short-term and long-term goals

Mr. Baron Night, President and CEO of SOHM, Inc., is pleased to inform its shareholders of activities in the pipeline for the company.

In continuation of our earlier tweet about our company’s engagement with domestic and international funds to assist our efforts of the company’s vertical integration expansions through various acquisitions, Mr. Night added, that the management is in discussion for the acquisition of 51% of the ownership of a Generic Pharmaceutical Distributor that has revenues of over $15 million ($15,000,000) with more than $2 million ($2,000,000)  in EBITDA. The target company has had a positive net profit for the past 5 years.

Mr. Night stated that the target company has accounts with 5,000+ independent pharmacies, purchases products from over 50 vendors, and is licensed to ship prescription and OTC pharmaceutical products to 45 states. The company is operated out of a state of the art 10,000 square foot facility. The target company warehouses and ships over 1000 SKU’s of various prescription and OTC products.

Once the deal goes through, the company will have the ability to reach for its products to almost the entire United States. Our estimation of the finishing due diligence is mid of Q4. This has been made possible due to an encouraging response from the international funds for their mandate given to the company. Mr. Baron Night added.

About SOHM, Inc.: SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India and a strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals were exported globally and introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To learn more about SOHM, Inc., visit

Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on

For more information, please contact:

SOHM, Inc.
Tel: 714-522-6700